Mechanisms predictive of Tibetan Medicine Sophora moorcroftiana alkaloids for treatment of lung cancer based on the network pharmacology and molecular docking

Peng Ji,Nian-Shou Zhao,Fan-Lin Wu,Yan-Ming Wei,Ci-Dan Laba,Cuo-Mu Wujin,Yong-Li Hua,Zi-Wen Yuan,Wan-Ling Yao

DOI: https://doi.org/10.1186/s12906-024-04342-3

2024-01-20

BMC Complementary Medicine and Therapies

Abstract:Abstract Background Leguminous Sophora moorcroftiana (SM) is a genuine medicinal material in Tibet. Many research results have reveal the Sophora moorcroftiana alkaloids (SMA), as the main active substance, have a wide range of effects, such as antibacterial, antitumor and antiparasitic effects. However, there are few reports on the inhibition of lung cancer (LC) and its inhibitory mechanism, and the pharmacological mechanism of SMA is still unclear, Therefore, exploring its mechanism of action is of great significance. Methods The SMA active components were obtained from the literature database. Whereas the corresponding targets were screened from the PubChem and PharmMapper database, UniProt database were conducted the correction and transformation of UniProt ID on the obtained targets. The GeneCards and OMIM databases identified targets associated with LC. Venny tools obtained the intersection targets of SMA and LC. R language and Cytoscape software constructed the visual of SMA - intersection targets – LC disease network. The intersection targets protein-protein interaction (PPI) network were built by the STRING database. The functions and pathways of the common targets of SMA and LC were enriched by gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG). Subsequently, molecular docking And A549 cells vitro experiment were performed to further validate our finding. Results We obtained six kinds of alkaloids in SM, 635 potential targets for these compounds, and 1,303 genes related to LC. SMA and LC intersection targets was 33, including ALB, CCND1, ESR1, NOTCH1 and AR. GO enrichment indicated that biological process of SMA was mainly involved in the positive regulation of transcription and nitric oxide biosynthetic process, and DNA-templated, etc. Biological functions were mainly involved in transcription factor binding and enzyme binding, etc. Cell components were mainly involved in protein complexes, extracellular exosome, cytoplasm and nuclear chromatin, etc., Which may be associated with its anti-LC effects. KEGG enrichment analysis showed that main pathways involved in the anti-LC effects of SMA, including pathway in cancer, non small-cell lung cancer, p53, PI3K-Akt and FOXO signaling pathways. Molecular docking analyses revealed that the six active compounds had a good binding activity with the main therapeutic targets 2W96, 2CCH and 1O96. Experiments in vitro proved that SMA inhibited the proliferation of LC A549 cells. Conclusions Results of the present study, we have successfully revealed the SMA compounds had a multi-target and multi-channel regulatory mechanism in treatment LC, These findings provided a solid theoretical reference of SMA in the clinical treatment of LC.

integrative & complementary medicine

What problem does this paper attempt to address?

The paper aims to explore the therapeutic effects and potential mechanisms of alkaloid components (SMA) in the commonly used Tibetan medicinal herb Sophora moorcroftiana (SM) on lung cancer (LC). Specifically, the paper addresses the following issues:

1. **Identification of active components in SMA and their potential targets**:
- Researchers screened six major alkaloid components from literature databases: matrine, oxymatrine, oxysophocarpine, sophocarpine, sophoridine, and cytisine.
- Potential targets of these components were predicted using the PharmMapper database and corrected and converted using the UniProt database, resulting in 635 potential targets.

2. **Identification of gene targets related to lung cancer**:
- Using the GeneCards and OMIM databases, researchers identified 1303 gene targets related to lung cancer.

3. **Construction of the intersection target network between SMA and lung cancer**:
- Through Venny tool analysis, 33 intersection targets between SMA and lung cancer were identified, including ALB, CCND1, ESR1, NOTCH1, and AR.

4. **Functional enrichment analysis**:
- Using GO and KEGG pathway analysis, the functions and signaling pathways of these intersection targets were studied. GO enrichment analysis indicated that the main biological processes of SMA involve transcription regulation and nitric oxide synthesis; molecular functions mainly involve transcription factor binding and enzyme binding; cellular components mainly involve protein complexes, extracellular vesicles, cytoplasm, and nuclear chromatin.
- KEGG enrichment analysis showed that the main pathways of SMA's anti-lung cancer effects include cancer pathways, non-small cell lung cancer, p53 signaling pathway, PI3K-Akt signaling pathway, and FoxO signaling pathway.

5. **Molecular docking validation**:
- Using molecular docking technology, the binding of these six alkaloids to key target proteins 2W96, 2CCH, and 1O96 was validated, showing good binding activity between these alkaloids and the target proteins.

6. **In vitro experimental validation**:
- In in vitro experiments, researchers found that SMA extracts had significant inhibitory effects on the lung cancer A549 cell line at different concentrations, showing dose- and time-dependent effects.

In summary, the paper reveals the multi-target and multi-pathway regulatory mechanisms of SMA in the treatment of lung cancer through network pharmacology, molecular docking technology, and in vitro experiments, providing a theoretical basis for the clinical treatment of lung cancer with SMA.